A Research Study for Patients With Overactive Bladder
NCT00168454
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
313
Enrollment
INDUSTRY
Sponsor class
Conditions
Overactive Bladder
Urinary Incontinence
Interventions
BIOLOGICAL:
botulinum toxin Type A
DRUG:
Placebo
Sponsor
Allergan